ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Critical Reviews™ in Eukaryotic Gene Expression
インパクトファクター: 1.841 5年インパクトファクター: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN 印刷: 1045-4403
ISSN オンライン: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.v6.i1.30
pages 29-57

Gene Therapy: Basic Concepts and Recent Advances

Deborah L. Sokol
Departments of Pathology and Laboratory Medicine,University of Pennsylvania School of Medicine, Philadelphia, PA 19104
Alan M. Gewirtz
Hematology/Oncology, University of Pennsylvania School of Medicine

要約

After years of preliminary in vitro and in vivo modeling, the first human gene therapy clinical trial was initiated ∼5 years ago. The experience gained from this trial, and the others that have come after it, has shown that effective and efficient human gene therapy remains a tantalizing but elusive goal. Nevertheless, interest in this area of therapeutics continues to grow and over 100 gene therapy protocols have now been submitted to the Recombinant DNA Advisory Committee ("RAC") of the National Institutes of Health for approval. The goal of these protocols vary, but include correction of inherited gene defects, engineering new traits into cells such as diminished chemosensitivity in the case of bone marrow cells, or, in the case of tumor cells, expression of new immunophenotypes. Marking cells with a gene whose function can easily be detected, thereby rendering the cell traceable in vitro and in vivo is also the goal of several clinical trials. At the same time, different means of gene transfer are been investigated for the efficiency with which they deliver "therapeutic nucleotides" into their cellular targets. In this review, we recount some of the major developments that have occurred in these various areas and discuss their impact on progess in the field.


Articles with similar content:

Antisense Oligonucleotide Therapeutics for Human Leukemia
Critical Reviews™ in Oncogenesis, Vol.8, 1997, issue 1
Alan M. Gewirtz
Oncogenic RAS: From Its Activation to Its Direct Targeting
Critical Reviews™ in Oncogenesis, Vol.22, 2017, issue 3-4
Apostolos Zaravinos
Options and Opportunities for Clinical Management and Treatment of Psoriasis
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.30, 2013, issue 1
Udita Agrawal, Devyani Dube, Madhu Gupta, Suresh P. Vyas
DNA Vaccines
Critical Reviews™ in Immunology, Vol.18, 1998, issue 5
Wayne C. Lai, Michael Bennett
p53 Binding to Target Sites Is Dynamically Regulated Before and After Ionizing Radiation-Mediated DNA Damage
Journal of Environmental Pathology, Toxicology and Oncology, Vol.23, 2004, issue 1
Alex Almasan, Marcela Oancea, Meredith E. Crosby